Abstract
This Article submits that the main problem with gene patents is the failure to meet the condition of alternativeness of inventions-a condition that embodies a core function of the patent system. As a result, gene patents conflict with the very rationale of the patent system.
Keywords
Biotechnology, Human genetics, Patent law, European Union, United States